Sally Jackson
Fortuna: 2 M $ al 31/07/2026
Fortuna: 2 M $ al 31/07/2026
Sally Jackson worked at GSK Plc from 2001 to 2026, serving as Senior VP-Global Communications & CEO-Office from 2019 to 2026.
Ms. Jackson completed undergraduate studies at the University of Cambridge.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GSK PLC 0 % | 09/12/2025 | 72.755 ( 0 % ) | 2 M $ | 31/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| GSK PLC | Public Communications Contact | 01/01/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.